What it's for (Indications)
- The information provided pertains to the combination of Clotrimazole and Hydrocortisone, commonly found in topical preparations like 'Clozole-H 10gm', as the combination of hydrochlorothiazide and clotrimazole is not a standard or recognized topical pharmaceutical product.
- This combination (Clotrimazole + Hydrocortisone) is indicated for the topical treatment of inflammatory fungal skin infections where inflammatory symptoms (such as pruritus, erythema, and swelling) are prominent.
- This includes conditions like tinea pedis, tinea cruris, tinea corporis, and candidiasis where an anti-inflammatory effect is desired in conjunction with antifungal action.
- The Clotrimazole component targets a broad spectrum of pathogenic fungi including dermatophytes, yeasts, and Malassezia species, while the Hydrocortisone component provides symptomatic relief by reducing inflammation and itching, making it suitable for dermatoses complicated by fungal infections or where a fungal etiology is suspected alongside significant inflammation.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For the combination of Clotrimazole and Hydrocortisone (e.g., Clozole-H 10gm), the typical dosage involves applying a thin layer of the cream or ointment to the affected skin areas once or twice daily, as directed by a healthcare professional. The medication should be gently rubbed into the skin. The duration of treatment should be limited, generally not exceeding 7 to 14 days, especially due to the corticosteroid component, to minimize the risk of local and systemic side effects. Prolonged use, particularly on the face, groin, or axillae, or under occlusive dressings, should be avoided. The 10gm quantity refers to the total amount of product in the tube, not the dosage per application. A 'pea-sized' amount is often sufficient for a small area. Pediatric use requires particular caution due to increased susceptibility to systemic absorption and HPA axis suppression. |
Safety & Warnings
Common Side Effects
- Common side effects for topical Clotrimazole and Hydrocortisone include local skin reactions such as burning, stinging, itching, irritation, erythema, dryness, and allergic contact dermatitis at the application site.
- Side effects specific to the hydrocortisone component may include skin atrophy (thinning), striae, telangiectasias, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, and perioral dermatitis, especially with prolonged or extensive use.
- Systemic side effects, though rare with appropriate topical use, can occur due to corticosteroid absorption, including reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria.
- Pediatric patients are at higher risk for systemic effects.
- If severe irritation or signs of hypersensitivity develop, treatment should be discontinued.
Serious Warnings
- Black Box Warning: It is imperative to clarify that the provided drug combination 'hydrochlorothiazide + clotrimazole' is not a recognized or standard pharmaceutical product, especially in a topical 10gm formulation. Hydrochlorothiazide is an oral systemic diuretic, not a topical agent. Given the example brand name 'Clozole-H 10gm,' which commonly refers to a combination of **Clotrimazole and Hydrocortisone** (a topical corticosteroid), the clinical information above has been provided for this widely recognized and clinically relevant topical combination. For topical Clotrimazole and Hydrocortisone, there is **no specific FDA-mandated Black Box Warning**. However, serious warnings related to the systemic absorption of the corticosteroid component are critical safety considerations. These include the potential for hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, and increased susceptibility to these effects in pediatric patients, with prolonged use, or with extensive application. Healthcare providers should diligently monitor patients for these potential systemic adverse events.
- Topical Clotrimazole and Hydrocortisone should be used with caution.
- The corticosteroid component (hydrocortisone) can be absorbed systemically, potentially leading to reversible HPA axis suppression, Cushing's syndrome, hyperglycemia, and glucosuria.
- This risk is amplified with prolonged use, extensive body surface area application, occlusive dressings, and in pediatric patients due to their higher surface area-to-weight ratio.
- The product is not intended for ophthalmic, oral, or intravaginal use; contact with eyes should be avoided.
- Discontinue use if irritation, sensitization, or superinfection occurs.
- Prolonged use can lead to local skin changes such as atrophy and may mask or worsen certain skin infections (e.
- g.
- , viral).
- If there is no improvement after a reasonable treatment period, the diagnosis should be re-evaluated.
- Avoid application to broken skin or mucous membranes.
How it Works (Mechanism of Action)
The therapeutic action of this combination product derives from its two active components: Clotrimazole and Hydrocortisone. Clotrimazole is an imidazole antifungal that functions by inhibiting the biosynthesis of ergosterol, an essential sterol component of fungal cell membranes. This disruption leads to an increase in cell membrane permeability, causing leakage of intracellular contents and ultimately fungal cell death, exhibiting both fungistatic and fungicidal activity. Hydrocortisone is a low-potency topical corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive effects. It achieves this by inducing phospholipase A2 inhibitory proteins (lipocortins), which control the biosynthesis of potent inflammation mediators like prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid, from membrane phospholipids. This dual mechanism effectively treats fungal infections while simultaneously alleviating associated inflammatory symptoms.
Commercial Brands (Alternatives)
No other brands found for this formula.